CALGARY, Alberta--(BUSINESS WIRE)--Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an oversubscribed $27 ...

To address concerns of late and very late stent thrombosis associated with first generation drug-eluting stent technology, novel approaches are being tested including stents with bioabsorbable ...

The potential for bioabsorbable polymer implants to replace metal in many applications has generated a great deal of buzz in recent years. However, a multiuniversity consortium is taking a ...

For about a decade, bioabsorbable stents were hailed as one of the most promising technologies in cardiology. Now, the future prospects of the technology are less than certain after a clinical trial ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Patients with more complex anatomy showed improved clinical outcomes with Biomatrix Flex including less cardiac death (HR: 0.43; 95% CI: 0.21–0.89; p = 0.02). In addition, low rates of definite stent ...